wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53362175-00250A10-493F-4E23-BAEE-732848F85164
Q53362175-00250A10-493F-4E23-BAEE-732848F85164
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53362175-00250A10-493F-4E23-BAEE-732848F85164
Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
P2860
Q53362175-00250A10-493F-4E23-BAEE-732848F85164
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53362175-00250A10-493F-4E23-BAEE-732848F85164
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
405efd95e86a4b3e95ed6271dc06252fdc3d6d58
P2860
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review.